✦ LIBER ✦

A phase II randomized, double-blind, parallel group, 26-week study of GSK-3 inhibitor tideglusib in Alzheimer's disease (ARGO trial)

✍ Scribed by del Ser, Teodoro; Lovestone, Simon; Boada-Rovira, Mercè; Dubois, Bruno; Hüll, Michael; Rinne, Juha; León, Teresa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

✍ Grove, Richard; Horrigan, Joseph; Harrington, Conn; Beresford, Isabel; Mahler, A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Efficacy and tolerability of oral budeso

✍ Suzuki, Yasuo; Motoya, Satoshi; Takazoe, Masakazu; Kosaka, Tadashi; Date, Masata 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 614 KB

Efficacy of Multivitamin Supplementation

✍ Yu Sun; Chien-Jung Lu; Kuo-Liong Chien; Sien-Tsong Chen; Rong-Chi Chen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

321 A RANDOMIZED, PARALLEL GROUP, DOUBLE

✍ C.E. Marrero; C. Tuten; T. Shamim; V. Awasty; J. Agaiby; D. Hassman; J. Sutphen; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A twelve-week, randomized, double-blind,

✍ EDWARDS1, E 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 26 KB

377 A Randomized, Double-Blind, Placebo-

✍ William G. Paterson; Jonathon Springer; Michael O'Mahony; Richard P. Reynolds; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 95 KB